Profile | GDS4284 / 225773_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 2447.67 | 86 |
GSM687648 | Patient 402 control | 2567.06 | 87 |
GSM687653 | Patient 403 control | 2182.61 | 85 |
GSM687658 | Patient 404 control | 2277.96 | 85 |
GSM687663 | Patient 411 control | 2590.46 | 87 |
GSM687668 | Patient 422 control | 2382.96 | 86 |
GSM687673 | Patient 424 control | 2443.6 | 86 |
GSM687678 | Patient 425 control | 2009.75 | 84 |
GSM687683 | Patient 427 control | 2387.48 | 86 |
GSM687688 | Patient 428 control | 1978.31 | 84 |
GSM687695 | Patient 441 control | 3570.68 | 91 |
GSM687699 | Patient 443 control | 1977.95 | 84 |
GSM687704 | Patient 444 control | 2264.55 | 85 |
GSM687707 | Patient 448 control | 1945.46 | 84 |
GSM687712 | Patient 449 control | 2833.21 | 88 |
GSM687719 | Patient 450 control | 2672.93 | 88 |
GSM687724 | Patient 451 control | 2583.73 | 87 |
GSM687728 | Patient 452 control | 2397.41 | 86 |
GSM687646 | Patient 401 treated 24h | 2152.79 | 85 |
GSM687649 | Patient 402 treated 24h | 2467.03 | 86 |
GSM687665 | Patient 411 treated 24h | 2698.61 | 88 |
GSM687651 | Patient 402 treated 4 weeks | 2470.83 | 87 |
GSM687667 | Patient 411 treated 4 weeks | 2453.91 | 86 |
GSM687670 | Patient 422 treated 24h | 2531.47 | 87 |
GSM687671 | Patient 422 treated 4 weeks | 2355.14 | 86 |
GSM687654 | Patient 403 treated 24h | 2521.5 | 87 |
GSM687675 | Patient 424 treated 24h | 2328.54 | 86 |
GSM687685 | Patient 427 treated 24h | 2463.01 | 86 |
GSM687656 | Patient 403 treated 4 weeks | 2177.54 | 85 |
GSM687677 | Patient 424 treated 4 weeks | 2438.75 | 86 |
GSM687687 | Patient 427 treated 4 weeks | 2167.01 | 85 |
GSM687692 | Patient 428 treated 4h | 2301.96 | 86 |
GSM687716 | Patient 449 treated 4h | 2264.25 | 85 |
GSM687722 | Patient 450 treated 4h | 2459.12 | 87 |
GSM687680 | Patient 425 treated 24h | 2359.27 | 86 |
GSM687690 | Patient 428 treated 24h | 2962.68 | 89 |
GSM687700 | Patient 443 treated 24h | 2047.09 | 85 |
GSM687705 | Patient 444 treated 24h | 2826.56 | 88 |
GSM687714 | Patient 449 treated 24h | 2530.03 | 87 |
GSM687721 | Patient 450 treated 24h | 2358.61 | 86 |
GSM687682 | Patient 425 treated 4 weeks | 2691.7 | 87 |
GSM687694 | Patient 428 treated 4 weeks | 2208.14 | 85 |
GSM687702 | Patient 443 treated 4 weeks | 2392.54 | 86 |
GSM687718 | Patient 449 treated 4 weeks | 2342.7 | 86 |
GSM687723 | Patient 450 treated 4 weeks | 2546.71 | 87 |
GSM687661 | Patient 404 treated 4h | 2583.23 | 87 |
GSM687710 | Patient 448 treated 4h | 2675.95 | 87 |
GSM687726 | Patient 451 treated 4h | 2391.3 | 86 |
GSM687730 | Patient 452 treated 4h | 3440.28 | 92 |
GSM687660 | Patient 404 treated 24h | 2944.68 | 89 |
GSM687697 | Patient 441 treated 24h | 2997.25 | 89 |
GSM687709 | Patient 448 treated 24h | 1897.34 | 83 |
GSM687725 | Patient 451 treated 24h | 2709.97 | 88 |
GSM687729 | Patient 452 treated 24h | 3001.28 | 89 |
GSM687727 | Patient 451 treated 4 weeks | 2233.27 | 85 |
GSM687731 | Patient 452 treated 4 weeks | 2651.04 | 87 |